RetourDate du jugement12 mai 2022JuridicitonIntellectual Property High Court of KoreaDegrés de juridictionPremière instanceType de procédureJudiciaire (administratif)SujetBrevets (Inventions)Plaignant/RequérantA (China)DéfendeurCommissioner of the Korean Intellectual Property Office Mots clés
Rejection,
Divisional application,
Pharmaceutical composition,
Pharmaceutical use invention,
IC50,
Description requirement of a specification,
Pharmacological mechanism,
Peramivir
Jugement/DécisionAnglaisIP High Court Decision, 2021Heo3758, dated May 12, 2022 PDFCoréen특허법원 2022. 5. 12 선고 2021허3758판결 PDFLégislation pertinente